+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

Schizophrenia Drugs Market, Size, Global Forecast Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Thumbnail Image

Schizophrenia Drugs Market, Size, Global Forecast Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • November 2023
  • 165 Pages
  • Global
From
Post-Traumatic Stress Disorder (PTSD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 189 Pages
  • Global
From
Schizophrenia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Schizophrenia Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 197 Pages
  • Global
From
Antipsychotic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antipsychotic Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 193 Pages
  • Global
From
Antidepressants - Global Strategic Business Report - Product Thumbnail Image

Antidepressants - Global Strategic Business Report

  • Report
  • May 2024
  • 174 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics: Global Strategic Business Report - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics: Global Strategic Business Report

  • Report
  • May 2024
  • 186 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 380 Pages
  • Global
From
Anxiolytics - Global Strategic Business Report - Product Thumbnail Image

Anxiolytics - Global Strategic Business Report

  • Report
  • May 2024
  • 78 Pages
  • Global
From
Global Psychedelic Drugs Market 2030 by Source, Drug Type, Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints - Product Thumbnail Image

Global Psychedelic Drugs Market 2030 by Source, Drug Type, Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints

  • Report
  • August 2023
  • 180 Pages
  • Global
From
Depression Drugs Market Report by Drug Class, Disorder Type, Drug Type, Distribution Channel, and Region 2024-2032 - Product Thumbnail Image

Depression Drugs Market Report by Drug Class, Disorder Type, Drug Type, Distribution Channel, and Region 2024-2032

  • Report
  • March 2024
  • 148 Pages
  • Global
From
Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2024-2032 - Product Thumbnail Image

Cognitive and Memory Enhancer Drugs Market Report by Product (Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and Others), Application (Disease Treatment, Athletic Performance, Academic Performance, and Others), and Region 2024-2032

  • Report
  • March 2024
  • 139 Pages
  • Global
From
Anxiety Disorder Treatment: Global Strategic Business Report - Product Thumbnail Image

Anxiety Disorder Treatment: Global Strategic Business Report

  • Report
  • May 2024
  • 196 Pages
  • Global
From
Seasonal Affective Disorder Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Seasonal Affective Disorder Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 120 Pages
  • Global
From
Global Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Global Anxiety Disorders and Depression Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 120 Pages
  • Global
From
Generalized Anxiety Disorder Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Generalized Anxiety Disorder Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • January 2024
  • 160 Pages
  • Global
From
Schizophrenia - Epidemiology Forecast - 2034 - Product Thumbnail Image

Schizophrenia - Epidemiology Forecast - 2034

  • Report
  • March 2024
  • 198 Pages
  • Global
From
Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • August 2023
  • 133 Pages
  • Global
From
LYBALVI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LYBALVI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
LATUDA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LATUDA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
REXULTI Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

REXULTI Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more